articleTop 1% cited

Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study

Atherosclerosis · 2018 · Vol. 277 · pp. 195–203

Christie M. Ballantyne✉(Baylor College of Medicine)Maciej Banach(Medical University of Lodz)G.B. John Mancini(University of British Columbia)Norman E. Lepor(Cedars-Sinai Medical Center)Jeffrey C. Hanselman(Esperion Therapeutics (United States))Xin Zhao(Esperion Therapeutics (United States))Lawrence A. Leiter(St. Michael's Hospital)

View via DOI Publisher page

Lipoproteins and Cardiovascular Health Cancer, Lipids, and Metabolism Diabetes, Cardiovascular Risks, and LipoproteinsEzetimibeFamilial hypercholesterolemiaStatinMedicinePlaceboRandomized controlled trialInternal medicineCholesterol

MeSH terms

EzetimibeAgedHypolipidemic AgentsCanadaDicarboxylic AcidsDouble-Blind MethodDrug Therapy, CombinationEuropeFatty AcidsFemaleHumansHypercholesterolemiaCholesterol, LDLMaleMiddle Aged